Can-Fite BioPharma Ltd. Accounts Payable and Other Accrued Liabilities
Can-Fite BioPharma Ltd. (CANF) had Accounts Payable and Other Accrued Liabilities of $1.11 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2026-03-26
- 2025-12-31: Accounts Payable and Other Accrued Liabilities $1.11M.
- 2024-12-31: Accounts Payable and Other Accrued Liabilities $976.00K.
- 2023-06-30: Accounts Payable and Other Accrued Liabilities $596.00K.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities $775.00K.
| Period end | Accounts Payable and Other Accrued Liabilities |
|---|---|
| 2025-12-31 | $1.11M 20-F · filed 2026-03-26 |
| 2024-12-31 | $976.00K 20-F · filed 2026-03-26 |
| 2023-06-30 | $596.00K 6-K · filed 2023-08-31 |
| 2022-12-31 | $775.00K 6-K · filed 2023-08-31 |
| 2022-06-30 | $464.00K 6-K · filed 2022-08-25 |
| 2021-12-31 | $905.00K 6-K · filed 2022-08-25 |
| 2021-06-30 | $309.00K 6-K · filed 2021-08-26 |
| 2020-12-31 | $331.00K 6-K · filed 2021-08-26 |